UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?

International journal of molecular sciences, 2020-04, Vol.21 (7), p.2620

2020

Volltextzugriff (PDF)

Editorial: Implementing new technologies for neuromuscular disorders

Frontiers in neurology, 2024-02, Vol.15, p.1370538-1370538

2024

Volltextzugriff (PDF)

Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy

International journal of molecular sciences, 2022-12, Vol.23 (24), p.16080

2022

Volltextzugriff (PDF)

Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy

Frontiers in immunology, 2022-12, Vol.13, p.1049076-1049076

2022

Volltextzugriff (PDF)

AdipoRon enhances healthspan in middle‐aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers

Journal of cachexia, sarcopenia and muscle, 2023-02, Vol.14 (1), p.464-478

2023

Volltextzugriff (PDF)

Challenging Sarcopenia: Exploring AdipoRon in Aging Skeletal Muscle as a Healthspan-Extending Shield

Antioxidants, 2024-09, Vol.13 (9), p.1073

2024

Volltextzugriff (PDF)

Walking down Skeletal Muscle Lane: From Inflammasome to Disease

Cells (Basel, Switzerland), 2021-11, Vol.10 (11), p.3023

2021

Volltextzugriff (PDF)

Cramp‐fasciculation syndrome associated with monofocal motor neuropathy

Muscle & nerve, 2017-10, Vol.56 (4), p.828-832

2017

Volltextzugriff (PDF)

The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle

Cells (Basel, Switzerland), 2023-08, Vol.12 (16), p.2101

2023

Volltextzugriff (PDF)

Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells

Journal of neurology, 2018-05, Vol.265 (5), p.1199-1209

2018

Volltextzugriff (PDF)

Science is 1% inspiration and 99% biomarkers

Multiple Sclerosis Journal, 2017-10, Vol.23 (11), p.1442-1452

2017

Volltextzugriff (PDF)

Inflammasome inhibitors for the treatment of muscular dystrophies (S29.006)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Combined central and peripheral demyelination: a case serie (1472)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Self-monitoring visual function in Neurology (S16.008)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Memory B Cells: Toward a Unified Therapeutic Target for Effective Immunotherapy in Multiple Sclerosis (P5.365)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient‐reported outcome measures

European journal of neurology, 2024-07, Vol.31 (7), p.e16282-n/a

2024

Volltextzugriff (PDF)

Disease modification in advanced MS: Focus on upper limb function

Multiple sclerosis, 2017-12, Vol.23 (14), p.1956-1957

2017

Volltextzugriff (PDF)

Cerebrospinal fluid NCAM levels are modulated by disease‐modifying therapies

Acta neurologica Scandinavica, 2019-05, Vol.139 (5), p.422-427

2019

Volltextzugriff (PDF)

Alemtuzumab depletion failure can occur in multiple sclerosis

Immunology, 2018-06, Vol.154 (2), p.253-260

2018

Volltextzugriff (PDF)

Inclusion criteria used in trials of people with progressive multiple sclerosis

Multiple sclerosis, 2020-03, Vol.26 (3), p.279-283

2020

Volltextzugriff (PDF)

Intravenous immunoglobulin-induced aseptic meningitis in a patient with Miller Fisher syndrome

Acta neurologica Belgica, 2020-08, Vol.120 (4), p.1015-1016

2020

Volltextzugriff (PDF)

PO124 Validation of an environmentally-friendly and affordable cardboard 9-hole peg test

Journal of neurology, neurosurgery and psychiatry, 2017-12, Vol.88 (Suppl 1), p.A44-A45

2017

Volltextzugriff (PDF)

PO151 Infections in patients with multiple sclerosis on alemtuzumab – should antibiotic prophylaxis be standard?

Journal of neurology, neurosurgery and psychiatry, 2017-12, Vol.88 (Suppl 1), p.A52-A53

2017

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(92)
Französisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?

Editorial: Implementing new technologies for neuromuscular disorders

Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy

Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy

AdipoRon enhances healthspan in middle‐aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers

Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation

Challenging Sarcopenia: Exploring AdipoRon in Aging Skeletal Muscle as a Healthspan-Extending Shield

Walking down Skeletal Muscle Lane: From Inflammasome to Disease

Cramp‐fasciculation syndrome associated with monofocal motor neuropathy

The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle

Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells

Science is 1% inspiration and 99% biomarkers

Inflammasome inhibitors for the treatment of muscular dystrophies (S29.006)

Combined central and peripheral demyelination: a case serie (1472)

Congenital Myasthenic Syndromes in Belgium: Genetic and Clinical Characterization of Pediatric and Adult Patients

Self-monitoring visual function in Neurology (S16.008)

Memory B Cells: Toward a Unified Therapeutic Target for Effective Immunotherapy in Multiple Sclerosis (P5.365)

Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient‐reported outcome measures

Disease modification in advanced MS: Focus on upper limb function

Cerebrospinal fluid NCAM levels are modulated by disease‐modifying therapies

Alemtuzumab depletion failure can occur in multiple sclerosis

Inclusion criteria used in trials of people with progressive multiple sclerosis

Intravenous immunoglobulin-induced aseptic meningitis in a patient with Miller Fisher syndrome

PO124 Validation of an environmentally-friendly and affordable cardboard 9-hole peg test

PO151 Infections in patients with multiple sclerosis on alemtuzumab – should antibiotic prophylaxis be standard?

Suchergebnisse filtern